Halozyme Therapeutics
HALO
#2257
Rank
NZ$14.41 B
Marketcap
NZ$121.54
Share price
-1.12%
Change (1 day)
35.24%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026NZ$9.26 M-80.55%
2025NZ$47.66 M99.47%
2024NZ$23.89 M-6.29%
2023NZ$25.5 M-15.59%
2022NZ$30.2 M38.39%
2021NZ$21.82 M-6.23%
2020NZ$23.27 M-44.23%
2019NZ$41.74 M591.9%
2018NZ$6.03 M-64.48%
2017NZ$16.98 M-5.65%
2016NZ$17.99 M-13.05%
2015NZ$20.7 M-7.81%
2014NZ$22.45 M140.61%
2013NZ$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
NZ$66.95 MNZ$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$62.76 MNZ$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$62.63 MNZ$0.42 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.4 MNZ$49.19 M๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
NZ$18.51 MNZ$98.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$2.61 MNZ$3.92 M๐Ÿ‡บ๐Ÿ‡ธ USA